IRIDEX Corp (IRIX) CFO adds 1,110 shares in open-market purchase

Rhea-AI Filing Summary

IRIDEX Corp’s Chief Financial Officer, Romeo R. Dizon, reported an open-market purchase of company stock. On March 6, 2026, he bought 1,110 shares of IRIDEX common stock at $1.26 per share. Following this transaction, his direct holdings increased to 121,000 shares.

Insider Trade Summary

Net Buyer: 1,110 shares ($1,399)

Net Buy 1 txn

Insider Dizon Romeo R

Role Chief Financial Officer

Bought 1,110 shs ($1K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,110	$1.26	$1K

Holdings After Transaction: Common Stock — 121,000 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CA 94043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		P		1,110	A	$1.26	121,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did IRIDEX (IRIX) disclose for Romeo R. Dizon?

IRIDEX disclosed that CFO Romeo R. Dizon bought 1,110 common shares. The shares were acquired in an open-market purchase at $1.26 per share, increasing his direct holdings to 121,000 shares after the transaction.

How many IRIDEX (IRIX) shares does the CFO own after this Form 4?

After the reported transaction, the CFO directly owns 121,000 IRIDEX shares. This reflects an increase from his prior position following the purchase of 1,110 common shares in an open-market transaction on March 6, 2026.

Was the IRIDEX (IRIX) CFO’s Form 4 transaction a buy or a sell?

The Form 4 reports a buy transaction by the IRIDEX CFO. Romeo R. Dizon executed an open-market purchase of 1,110 shares of common stock at a price of $1.26 per share, increasing his direct ownership.

At what price did the IRIDEX (IRIX) CFO purchase shares in the latest filing?

The CFO bought IRIDEX common stock at $1.26 per share. On March 6, 2026, Romeo R. Dizon acquired 1,110 shares in an open-market transaction, as disclosed in the Form 4 insider trading report.

What type of transaction is reported in IRIDEX (IRIX) CFO’s Form 4?

The Form 4 reports an open-market purchase of common stock. CFO Romeo R. Dizon acquired 1,110 IRIDEX shares at $1.26 per share, and the filing classifies the trade as a non-derivative, direct ownership transaction.